XOMA Corp. Stock
XOMA Corp. Stock
A loss of -1.690% shows a downward development for XOMA Corp..
Our community is currently high on XOMA Corp. with 5 Buy predictions and 0 Sell predictions.
Based on the current price of 23.2 € the target price of 68 € shows a potential of 193.1% for XOMA Corp. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for XOMA Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of XOMA Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of XOMA Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| XOMA Corp. | -1.690% | -0.840% | 14.563% | 44.785% | 39.645% | -19.728% | 115.643% |
| Ardelyx Inc. | 0.830% | -1.275% | -10.651% | 49.136% | 4.498% | -13.094% | - |
| Salarius Pharmaceuticals Inc. | -0.470% | 0.472% | 0.472% | -70.417% | -23.243% | -98.362% | -99.993% |
| Brainstorm Cell | -5.760% | -2.456% | -5.429% | -82.011% | 114.009% | -82.879% | - |
Comments
XOMA Co. (NASDAQ: XOMA) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $40.00 price target on the stock.
Show more
Ratings data for XOMA provided by MarketBeat
XOMA Co. (NASDAQ: XOMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $74.00 price target on the stock.
Show more
Ratings data for XOMA provided by MarketBeat
XOMA Co. (NASDAQ: XOMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $74.00 price target on the stock.
Show more
Ratings data for XOMA provided by MarketBeat